Dual versus single long‐acting bronchodilator use could raise acute coronary syndrome risk by over 50%: A population‐based nested case

Dual versus single long‐acting bronchodilator use could raise acute coronary syndrome risk by over 50%: A population‐based nested case–control study

Published:2021-07-21 Issue:5 Volume:290 Page:1028-1038
ISSN:0954-6820
Container-title:Journal of Internal Medicine
language:en
Short-container-title:J Intern Med

Author:

Parkin Lianne¹²,Williams Sheila¹,Sharples Katrina²³⁴,Barson David¹²,Horsburgh Simon¹²,Jackson Rod⁵,Wu Billy⁵,Dummer Jack²⁴

Affiliation:

1. Department of Preventive and Social Medicine Otago Medical School–Dunedin Campus University of Otago Dunedin New Zealand

2. Pharmacoepidemiology Research Network University of Otago Dunedin New Zealand

3. Department of Mathematics and Statistics University of Otago Dunedin New Zealand

4. Department of Medicine Otago Medical School–Dunedin Campus University of Otago Dunedin New Zealand

5. Department of Epidemiology and Biostatistics Faculty of Medical and Health Sciences University of Auckland Auckland New Zealand

Publisher

Wiley

Subject

Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/joim.13348

Reference42 articles.

1. World Health Organization.Global health estimates 2016: disease burden by cause age sex by country and by region 2000–2016.2018.www.who.int/healthinfo/global_burden_disease/estimates/en/index1.htmlAccessed 1 June 2020.

2. Ministry of Health.Health Loss in New Zealand 1990–2013: A Report from the New Zealand Burden of Diseases Injuries and Risk Factors Study.2016.www.health.govt.nz/publication/health‐loss‐new‐zealand‐1990‐2013Accessed 1 June 2020.

3. Cardiovascular disease risk prediction equations in 400 000 primary care patients in New Zealand: a derivation and validation study

4. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extrapulmonary Comorbidities Associated with Chronic Obstructive Pulmonary Disease: A Review;International Journal of Chronic Obstructive Pulmonary Disease;2024-02

2. Cardiovascular Diseases in COPD: From Diagnosis and Prevalence to Therapy;Life;2023-05-31

3. Inhaled therapy, cardiovascular risk and benefit–risk considerations in COPD: innocent until proven guilty, orvice versa?;European Respiratory Journal;2023-02

4. Pharmacotherapy of LAMA/LABA inhaled therapy combinations for chronic obstructive pulmonary disease: a clinical overview;Expert Review of Clinical Pharmacology;2022-11-02

5. Cardiovascular disease in chronic obstructive pulmonary disease: a narrative review;Thorax;2022-06-30